Shilpa Medicare Limited — Important, 12-08-2025: General Updates

Shilpa Medicare's wholly-owned subsidiary, Shilpa Pharma Lifesciences (SPL), has successfully redeemed all its outstanding Non-Convertible Debentures (NCDs). This significant development means SPL is now completely free of these specific debt instruments. For Shilpa Medicare, this action strengthens the group's consolidated balance sheet by reducing its overall financial leverage and improving its debt profile. A positive step towards greater financial flexibility and stability for the company.